Guang-Gui Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Guang-Gui Zeng has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Wan-Li Jiang
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.; Departments of Clinical Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China
5 shared publicationsGui-Ying Nie
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China
3 shared publicationsJiang Yu
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan, China
3 shared publications- Chao-Ke Tang
Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, 2020 Grade Excellent Doctor Class of Hengyang Medical College, University of South China, Hengyang, Hunan 421001, China
2 shared publications - Kang Zheng
Department of Clinical Laboratory, Hengyang Central Hospital, Hengyang, China
2 shared publications Chang-Kai Xiao
Department of Urology, Hengyang Medical School, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China
1 shared publication
Latest Publications
- Open Access
- 21 January 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (1)
Caspase Recruitment Domain Family Member 8: A Favorable Target in the Pathogenesis of Atherosclerosis
Atherosclerosis, a lipid-driven chronic inflammatory disease, is the primary pathological basis of cardiovascular diseases, characterized by endothelial injury, lipid deposition, immune cell infiltration, and chronic inflammation. The NOD-like Receptor Pyrin Domain-Containing 3 (NLRP3) inflammasome has emerged as a crucial mediator of inflammation in atherosclerosis, with caspase recruitment domain family member 8 (CARD8) acting as a key regulatory component. Indeed, CARD8, a member of the caspase recruitment domain family, regulates immune responses by modulating inflammasome activity, particularly NLRP3. Recent studies suggest that CARD8 influences various aspects of atherosclerotic development, including lipid accumulation, oxidative stress, vascular inflammation, smooth muscle cell proliferation, and plaque instability. Thus, this review summarizes the latest findings on the role of CARD8 in the pathogenesis of atherosclerosis, with a focus on the regulatory effects of this component on immune cells and inflammatory pathways. We also discuss the potential of targeting CARD8 as a therapeutic strategy for atherosclerosis, exploring the current preclinical and clinical evidence.
- 21 January 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (1)
Open AccessCaspase Recruitment Domain Family Member 8: A Favorable Target in the Pathogenesis of Atherosclerosis
Atherosclerosis, a lipid-driven chronic inflammatory disease, is the primary pathological basis of cardiovascular diseases, characterized by endothelial injury, lipid deposition, immune cell infiltration, and chronic inflammation. The NOD-like Receptor Pyrin Domain-Containing 3 (NLRP3) inflammasome has emerged as a crucial mediator of inflammation in atherosclerosis, with caspase recruitment domain family member 8 (CARD8) acting as a key regulatory component. Indeed, CARD8, a member of the caspase recruitment domain family, regulates immune responses by modulating inflammasome activity, particularly NLRP3. Recent studies suggest that CARD8 influences various aspects of atherosclerotic development, including lipid accumulation, oxidative stress, vascular inflammation, smooth muscle cell proliferation, and plaque instability. Thus, this review summarizes the latest findings on the role of CARD8 in the pathogenesis of atherosclerosis, with a focus on the regulatory effects of this component on immune cells and inflammatory pathways. We also discuss the potential of targeting CARD8 as a therapeutic strategy for atherosclerosis, exploring the current preclinical and clinical evidence.
- 30 November 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (2) , 102226
An innovative viewpoint on the existing and prospectiveness of SR-B1
- 30 November 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (2) , 102226
An innovative viewpoint on the existing and prospectiveness of SR-B1
- 22 October 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102161
A new perspective on the current and future development potential of ABCG1
- 22 October 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102161
A new perspective on the current and future development potential of ABCG1
- 5 October 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102116
The Potential Relationship Between Cardiovascular Diseases and Monkeypox
- 5 October 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102116
The Potential Relationship Between Cardiovascular Diseases and Monkeypox
- 21 September 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102096
A Potential Role of NFIL3 in Atherosclerosis
- 21 September 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102096
A Potential Role of NFIL3 in Atherosclerosis
- 15 September 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102088
Apelin-13: A Protective Role in Vascular Diseases
- 15 September 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (1) , 102088
Apelin-13: A Protective Role in Vascular Diseases